3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
Specimen Handling
21
Magnetic Resonance Spectroscopy
17
Carboplatin
16
Gemcitabine
14
pembrolizumab
11
Paclitaxel
11
Cisplatin
11
Interviews as Topic
10
Injections
10
fludarabine
9
Radiotherapy
8
Oxaliplatin
8
Nivolumab
8
Dexamethasone
8
Cyclophosphamide
8
Irinotecan
7
Fluorouracil
7
Bortezomib
7
Biopsy
7
Bevacizumab
7
toripalimab
6
Radiosurgery
5
Pemetrexed
5
Leucovorin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
trastuzumab deruxtecan
4
liposomal doxorubicin
4
cemiplimab
4
X-Rays
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
treosulfan
×
30 days
×
Clear all
NCT07598110
2026-05-20
FT-RIC-HAPLO
Institut Paoli-Calmettes
Phase 2
Not yet recruiting
77 enrolled